Efficacy of Bravecto® Plus spot-on solution for cats (280 mg/ml fluralaner and 14 mg/ml moxidectin) for the prevention of aelurostrongylosis in experimentally infected cats

Efficacy of Bravecto® Plus spot-on solution for cats (280 mg/ml fluralaner and 14 mg/ml moxidectin) for the prevention of aelurostrongylosis in experimentally infected cats

Abstract Background The feline lungworm Aelurostrongylus abstrusus affects the lower respiratory tract in cats worldwide. As infections may lead to chronic respiratory changes or even death, preventive treatment in cats with outdoor access is warranted. Methods The preventive efficacy of a spot-on s...

Full description

Bibliographic Details
Main Authors: Katharina Raue, Nadja Rohdich, Daniela Hauck, Eva Zschiesche, Simone Morelli, Donato Traversa, Angela Di Cesare, Rainer K. A. Roepke, Christina Strube
Format: Article
Language:English
Published: BMC 2021-02-01
Series:Parasites & Vectors
Subjects:
Aelurostrongylus abstrusus
Feline lungworms
Macrocyclic lactones
Moxidectin
Treatment
Prevention
Online Access:https://doi.org/10.1186/s13071-021-04610-y

Internet

https://doi.org/10.1186/s13071-021-04610-y

Similar Items